- Home
- PKOH vs ANNX Comparison
PKOH vs ANNX Comparison
Compare PKOH & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKOH
- ANNX
- Stock Information
- Founded
- PKOH 1907
- ANNX 2011
- Country
- PKOH United States
- ANNX United States
- Employees
- PKOH N/A
- ANNX N/A
- Industry
- PKOH Industrial Specialties
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- PKOH Industrials
- ANNX Health Care
- Exchange
- PKOH Nasdaq
- ANNX Nasdaq
- Market Cap
- PKOH 308.8M
- ANNX 253.8M
- IPO Year
- PKOH N/A
- ANNX 2020
- Fundamental
- Price
- PKOH $21.62
- ANNX $2.60
- Analyst Decision
- PKOH
- ANNX Strong Buy
- Analyst Count
- PKOH 0
- ANNX 5
- Target Price
- PKOH N/A
- ANNX $13.00
- AVG Volume (30 Days)
- PKOH 25.5K
- ANNX 1.6M
- Earning Date
- PKOH 11-05-2025
- ANNX 11-13-2025
- Dividend Yield
- PKOH 2.33%
- ANNX N/A
- EPS Growth
- PKOH 41.57
- ANNX N/A
- EPS
- PKOH 2.02
- ANNX N/A
- Revenue
- PKOH $1,611,500,000.00
- ANNX N/A
- Revenue This Year
- PKOH $0.23
- ANNX N/A
- Revenue Next Year
- PKOH $3.07
- ANNX N/A
- P/E Ratio
- PKOH $7.97
- ANNX N/A
- Revenue Growth
- PKOH N/A
- ANNX N/A
- 52 Week Low
- PKOH $15.52
- ANNX $1.29
- 52 Week High
- PKOH $34.50
- ANNX $7.85
- Technical
- Relative Strength Index (RSI)
- PKOH 63.27
- ANNX 61.39
- Support Level
- PKOH $21.45
- ANNX $2.32
- Resistance Level
- PKOH $22.20
- ANNX $2.70
- Average True Range (ATR)
- PKOH 0.54
- ANNX 0.15
- MACD
- PKOH 0.08
- ANNX 0.06
- Stochastic Oscillator
- PKOH 72.20
- ANNX 82.34
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.